Secondary hypothyroidism
|
0.100 |
Biomarker
|
disease |
BEFREE |
The latest age at diagnosis of GH, ACTH and TSH deficiencies was 9.6, 9.9 and 12.6 years, respectively.
|
31811804 |
2020 |
Secondary hypothyroidism
|
0.100 |
Biomarker
|
disease |
BEFREE |
The gonadotrophin, growth hormone and TSH deficiencies are better defined in the chronic phase.
|
30931510 |
2019 |
Secondary hypothyroidism
|
0.100 |
Biomarker
|
disease |
BEFREE |
The phenotype is likely due to hypothalamic dysfunction, which is responsible for hyperphagia, temperature instability, high pain threshold, hypersomnia and multiple endocrine abnormalities including growth hormone and thyroid-stimulating hormone deficiencies, hypogonadism and central adrenal insufficiency.
|
26062517 |
2015 |
Secondary hypothyroidism
|
0.100 |
Biomarker
|
disease |
BEFREE |
Endocrinological evaluation revealed growth hormone and thyroid-stimulating hormone deficiency.
|
26302767 |
2015 |
Secondary hypothyroidism
|
0.100 |
Biomarker
|
disease |
BEFREE |
Mutations within POU1F1 are associated with GH, TSH and PRL deficiencies, with the TSH deficiency being highly variable.
|
18174732 |
2007 |
Secondary hypothyroidism
|
0.100 |
Biomarker
|
disease |
BEFREE |
Their clinical follow-up showed a wide phenotypic variability: hypogonadism was severe and prevented pubertal development in both, but their final heights were remarkably different, pointing to different degrees in severity of GH/TSH deficiencies; cortisol deficiency developed late in both, but at least 10 yr apart.
|
17526949 |
2006 |
Secondary hypothyroidism
|
0.100 |
Biomarker
|
disease |
BEFREE |
TSH deficiency was manifested after the initiation of GH and was treated with thyroxine while puberty was initiated with conjugated estrogens.
|
17162714 |
2006 |
Secondary hypothyroidism
|
0.100 |
Biomarker
|
disease |
BEFREE |
Studies on Snell and Jackson mice known to have growth hormone, prolactin and thyroid-stimulating hormone deficiencies involving the hypoplastic pituitary gland have led to identifying alterations of the pituitary specific POU homeodomain Pit-1 transcription factor gene.
|
16879162 |
2006 |
Secondary hypothyroidism
|
0.100 |
Biomarker
|
disease |
BEFREE |
Growth hormone and thyroid-stimulating hormone deficiencies were diagnosed concomitantly in all subjects, but at different ages (5.5-10.8 years).
|
14614227 |
2003 |
Secondary hypothyroidism
|
0.100 |
Biomarker
|
disease |
BEFREE |
Pit-1 gene mutations result in complete growth hormone (GH) and PRL deficiencies and variable degrees of TSH deficiency, producing the clinical syndrome of combined pituitary hormone deficiency (CPHD).
|
9588494 |
1998 |
Secondary hypothyroidism
|
0.100 |
Biomarker
|
disease |
BEFREE |
We report a child whose hypothyroidism was recognized clinically at age 6 weeks, and subsequently found to have GH and Prl as well as TSH deficiency.
|
9485179 |
1998 |
Secondary hypothyroidism
|
0.100 |
Biomarker
|
disease |
BEFREE |
However, as the involvement of PIT1 mutation is rare in Russia, the other negative cases need to be analyzed for another candidate gene responsible for combined GH/Pr/TSH deficiency.
|
9632165 |
1998 |
Secondary hypothyroidism
|
0.100 |
Biomarker
|
disease |
BEFREE |
Four out of 10 children in two unrelated families presented with a total pituitary growth hormone (GH) and prolactin deficiency and a partial thyrotropin (TSH) deficiency.The GH gene was intact in family I.
|
2634610 |
1989 |